Gold Nanoparticles for Nucleic Acid Delivery

Anderson, 1992, Human gene therapy, Science, 256, 808, 10.1126/science.1589762 Mulligan, 1993, The basic science of gene therapy, Science, 260, 926, 10.1126/science.8493530 Bonadio, 1999, Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration, Nat Med, 5, 753, 10.1038/10473 Zhao, 2011, Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells, Gene Ther, 18, 220, 10.1038/gt.2010.123 Hamilton, 1999, A species of small antisense RNA in posttranscriptional gene silencing in plants, Science, 286, 950, 10.1126/science.286.5441.950 Sokolova, 2008, Inorganic nanoparticles as carriers of nucleic acids into cells, Angew Chem Int Ed Engl, 47, 1382, 10.1002/anie.200703039 Walther, 2000, Viral vectors for gene transfer: a review of their use in the treatment of human diseases, Drugs, 60, 249, 10.2165/00003495-200060020-00002 Kay, 2001, Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics, Nat Med, 7, 33, 10.1038/83324 Takahashi, 2009, Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy, Adv Drug Deliv Rev, 61, 760, 10.1016/j.addr.2009.04.006 Semple, 2010, Rational design of cationic lipids for siRNA delivery, Nat Biotechnol, 28, 172, 10.1038/nbt.1602 Wu, 2012, Biodegradable arginine-based poly(ether ester amide)s as a non-viral DNA delivery vector and their structure–function study, J Mater Chem, 22, 18983, 10.1039/c2jm33753c Yamanouchi, 2008, Biodegradable arginine-based poly(ester-amide)s as non-viral gene delivery reagents, Biomaterials, 29, 3269, 10.1016/j.biomaterials.2008.04.026 Dufès, 2005, Dendrimers in gene delivery, Adv Drug Deliv Rev, 57, 2177, 10.1016/j.addr.2005.09.017 Kichler, 1998, Influence of the DNA complexation medium on the transfection efficiency of lipospermine/DNA particles, Gene Ther, 5, 855, 10.1038/sj.gt.3300658 Dalby, 2004, Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications, Methods, 33, 95, 10.1016/j.ymeth.2003.11.023 Pantarotto, 2004, Functionalized carbon nanotubes for plasmid DNA gene delivery, Angew Chem Int Ed Engl, 43, 5242, 10.1002/anie.200460437 Kam, 2005, Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing, J Am Chem Soc, 127, 12492, 10.1021/ja053962k Biju, 2012, FRET from quantum dots to photodecompose undesired acceptors and report the condensation and decondensation of plasmid DNA, ACS Nano, 6, 3776, 10.1021/nn2048608 Chen, 2005, Quantum dots to monitor RNAi delivery and improve gene silencing, Nucleic Acids Res, 33, e190, 10.1093/nar/gni188 Kievit, 2009, PEI-PEG-Chitosan Copolymer Coated Iron Oxide Nanoparticles for Safe Gene Delivery: synthesis, complexation, and transfection, Adv Funct Mater, 19, 2244, 10.1002/adfm.200801844 Arsianti, 2010, Assembly of polyethylenimine-based magnetic iron oxide vectors: insights into gene delivery, Langmuir, 26, 7314, 10.1021/la9041919 Ghosh, 2008, Gold nanoparticles in delivery applications, Adv Drug Deliv Rev, 60, 1307, 10.1016/j.addr.2008.03.016 Boisselier, 2009, Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity, Chem Soc Rev, 38, 1759, 10.1039/b806051g Rana, 2012, Monolayer coated gold nanoparticles for delivery applications, Adv Drug Deliv Rev, 64, 200, 10.1016/j.addr.2011.08.006 Jewell, 2011, Oligonucleotide delivery by cell-penetrating “striped” nanoparticles, Angew Chem Int Ed Engl, 50, 12312, 10.1002/anie.201104514 Kim, 2013, The role of surface functionality in determining nanoparticle cytotoxicity, Acc Chem Res, 46, 681, 10.1021/ar3000647 Gindy, 2009, Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy, Expert Opin Drug Deliv, 6, 865, 10.1517/17425240902932908 Panyala, 2009, Gold and nano-gold in medicine: overview, toxicology and perspectives, J Appl Biomed, 7, 75, 10.32725/jab.2009.008 Park, 2009, New generation of multifunctional nanoparticles for cancer imaging and therapy, Adv Funct Mater, 19, 1553, 10.1002/adfm.200801655 Beaux, 2008, Utilization of solid nanomaterials for drug delivery, Expert Opin Drug Deliv, 5, 725, 10.1517/17425247.5.7.725 Roca, 2008, Probing cells with noble metal nanoparticle aggregates, Nanomedicine (Lond), 3, 555, 10.2217/17435889.3.4.555 Sanvicens, 2008, Multifunctional nanoparticles–properties and prospects for their use in human medicine, Trends Biotechnol, 26, 425, 10.1016/j.tibtech.2008.04.005 Bhattacharya, 2008, Biological properties of “naked” metal nanoparticles, Adv Drug Deliv Rev, 60, 1289, 10.1016/j.addr.2008.03.013 Xu, 2006, Inorganic nanoparticles as carriers for efficient cellular delivery, Chem Eng Sci, 61, 1027, 10.1016/j.ces.2005.06.019 Daniel, 2004, Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology, Chem Rev, 104, 293, 10.1021/cr030698+ Shenhar, 2003, Nanoparticles: scaffolds and building blocks, Acc Chem Res, 36, 549, 10.1021/ar020083j Sun, 2002, Shape-controlled synthesis of gold and silver nanoparticles, Science, 298, 2176, 10.1126/science.1077229 Brust, 1994, ). Synthesis of thiol-derivatized gold nanoparticles in a 2-phase liquid-liquid system, J Chem Soc, Chem Commun, 7, 801, 10.1039/C39940000801 Bowman, 2008, Inhibition of HIV fusion with multivalent gold nanoparticles, J Am Chem Soc, 130, 6896, 10.1021/ja710321g Ryan, 2007, Cellular uptake of gold nanoparticles passivated with BSA-SV40 large T antigen conjugates, Anal Chem, 79, 9150, 10.1021/ac0715524 Chompoosor, 2010, The role of surface functionality on acute cytotoxicity, ROS generation and DNA damage by cationic gold nanoparticles, Small, 6, 2246, 10.1002/smll.201000463 Zhu, 2010, Surface properties dictate uptake, distribution, excretion, and toxicity of nanoparticles in fish, Small, 6, 2261, 10.1002/smll.201000989 De Jong, 2008, Particle size-dependent organ distribution of gold nanoparticles after intravenous administration, Biomaterials, 29, 1912, 10.1016/j.biomaterials.2007.12.037 Sonavane, 2008, Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size, Colloids Surf B Biointerfaces, 66, 274, 10.1016/j.colsurfb.2008.07.004 Wang, 2013, Metabolism of nanomaterials in vivo: blood circulation and organ clearance, Acc Chem Res, 46, 761, 10.1021/ar2003336 Longmire, 2008, Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats, Nanomedicine (Lond), 3, 703, 10.2217/17435889.3.5.703 Zhu, 2013, Understanding the particokinetics of engineered nanomaterials for safe and effective therapeutic applications, Small, 9, 1619, 10.1002/smll.201201630 Pakiari, 2010, Nature and strength of M-S bonds (m = Au, Ag, and Cu) in binary alloy gold clusters, J Phys Chem A, 114, 9212, 10.1021/jp100423b Mirkin, 1996, A DNA-based method for rationally assembling nanoparticles into macroscopic materials, Nature, 382, 607, 10.1038/382607a0 Rosi, 2006, Oligonucleotide-modified gold nanoparticles for intracellular gene regulation, Science, 312, 1027, 10.1126/science.1125559 Ghildiyal, 2009, Small silencing RNAs: an expanding universe, Nat Rev Genet, 10, 94, 10.1038/nrg2504 Giljohann, 2009, Gene regulation with polyvalent siRNA-nanoparticle conjugates, J Am Chem Soc, 131, 2072, 10.1021/ja808719p Lytton-Jean, 2011, Five years of siRNA delivery: spotlight on gold nanoparticles, Small, 7, 1932, 10.1002/smll.201100761 Seferos, 2009, Polyvalent DNA nanoparticle conjugates stabilize nucleic acids, Nano Lett, 9, 308, 10.1021/nl802958f Giljohann, 2010, Gold nanoparticles for biology and medicine, Angew Chem Int Ed Engl, 49, 3280, 10.1002/anie.200904359 Patel, 2010, Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles, Bioconjug Chem, 21, 2250, 10.1021/bc1002423 Giljohann, 2007, Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles, Nano Lett, 7, 3818, 10.1021/nl072471q Jin, 2003, What controls the melting properties of DNA-linked gold nanoparticle assemblies?, J Am Chem Soc, 125, 1643, 10.1021/ja021096v Choi, 2013, Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates, Proc Natl Acad Sci U S A, 110, 7625, 10.1073/pnas.1305804110 Zhang, 2012, Antibody-linked spherical nucleic acids for cellular targeting, J Am Chem Soc, 134, 16488, 10.1021/ja306854d Hao, 2011, Nucleic acid-gold nanoparticle conjugates as mimics of microRNA, Small, 7, 3158, 10.1002/smll.201101018 Chen, 2012, Progress on RNAi-based molecular medicines, Int J Nanomedicine, 7, 3971, 10.2147/IJN.S31897 Oishi, 2006, Smart PEGylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing, Chem Lett, 35, 1046, 10.1246/cl.2006.1046 Prausnitz, 2004, Current status and future potential of transdermal drug delivery, Nat Rev Drug Discov, 3, 115, 10.1038/nrd1304 Prausnitz, 2008, Transdermal drug delivery, Nat Biotechnol, 26, 1261, 10.1038/nbt.1504 Zheng, 2012, Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation, Proc Natl Acad Sci U S A, 109, 11975, 10.1073/pnas.1118425109 Nel, 2009, Understanding biophysicochemical interactions at the nano-bio interface, Nat Mater, 8, 543, 10.1038/nmat2442 Lévy, 2010, Gold nanoparticles delivery in mammalian live cells: a critical review, Nano Rev, 1, 4889, 10.3402/nano.v1i0.4889 Gilleron, 2013, Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape, Nat Biotechnol, 31, 638, 10.1038/nbt.2612 Massich, 2009, Regulating immune response using polyvalent nucleic acid-gold nanoparticle conjugates, Mol Pharm, 6, 1934, 10.1021/mp900172m McIntosh, 2001, Inhibition of DNA transcription using cationic mixed monolayer protected gold clusters, J Am Chem Soc, 123, 7626, 10.1021/ja015556g Sandhu, 2002, Gold nanoparticle-mediated transfection of mammalian cells, Bioconjug Chem, 13, 3, 10.1021/bc015545c Han, 2006, Stability of gold nanoparticle-bound DNA toward biological, physical, and chemical agents, Chem Biol Drug Des, 67, 78, 10.1111/j.1747-0285.2005.00324.x Goodman, 2006, DNA-binding by functionalized gold nanoparticles: mechanism and structural requirements, Chem Biol Drug Des, 67, 297, 10.1111/j.1747-0285.2006.00372.x Thomas, 2003, Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells, Proc Natl Acad Sci U S A, 100, 9138, 10.1073/pnas.1233634100 You, 2005, Tunable inhibition and denaturation of alpha-chymotrypsin with amino acid-functionalized gold nanoparticles, J Am Chem Soc, 127, 12873, 10.1021/ja0512881 You, 2008, Isomeric control of protein recognition with amino acid- and dipeptide-functionalized gold nanoparticles, Chemistry, 14, 143, 10.1002/chem.200701234 Ghosh, 2007, Nanoparticles featuring amino acid-functionalized side chains as DNA receptors, Chem Biol Drug Des, 70, 13, 10.1111/j.1747-0285.2007.00534.x Ghosh, 2008, Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles, ACS Nano, 2, 2213, 10.1021/nn800507t Kim, 2012, Dendronized gold nanoparticles for siRNA delivery, Small, 8, 3253, 10.1002/smll.201201141 Yang, 2008, Release of cationic polymer-DNA complexes from the endosome: a theoretical investigation of the proton sponge hypothesis, J Chem Phys, 129, 185105, 10.1063/1.3009263 Behr, 1997, The proton sponge: a trick to enter cells the viruses did not exploit, Chimia, 51, 34, 10.2533/chimia.1997.34 Chou, 2011, Strategies for the intracellular delivery of nanoparticles, Chem Soc Rev, 40, 233, 10.1039/C0CS00003E Benjaminsen, 2013, The possible “proton sponge “ effect of polyethylenimine (PEI) does not include change in lysosomal pH, Mol Ther, 21, 149, 10.1038/mt.2012.185 Elbakry, 2009, Layer-by-layer assembled gold nanoparticles for siRNA delivery, Nano Lett, 9, 2059, 10.1021/nl9003865 Guo, 2010, Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte, ACS Nano, 4, 5505, 10.1021/nn101638u Anderson, 1998, Glutathione: an overview of biosynthesis and modulation, Chem Biol Interact, 111, 112 Hong, 2006, Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers, J Am Chem Soc, 128, 1078, 10.1021/ja056726i Han, 2006, Light-regulated release of DNA and its delivery to nuclei by means of photolabile gold nanoparticles, Angew Chem Int Ed Engl, 45, 3165, 10.1002/anie.200600214 Weissleder, 2001, A clearer vision for in vivo imaging, Nat Biotechnol, 19, 316, 10.1038/86684 Pissuwan, 2011, The forthcoming applications of gold nanoparticles in drug and gene delivery systems, J Control Release, 149, 65, 10.1016/j.jconrel.2009.12.006 Chen, 2006, DNA-gold nanorod conjugates for remote control of localized gene expression by near infrared irradiation, J Am Chem Soc, 128, 3709, 10.1021/ja0570180 Wijaya, 2009, Selective release of multiple DNA oligonucleotides from gold nanorods, ACS Nano, 3, 80, 10.1021/nn800702n Chithrani, 2006, Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells, Nano Lett, 6, 662, 10.1021/nl052396o Chen, 2009, Quantitative investigation of compartmentalized dynamics of ErbB2 targeting gold nanorods in live cells by single molecule spectroscopy, ACS Nano, 3, 4071, 10.1021/nn900743v